ClinicalTrials.gov
ClinicalTrials.gov Menu

Digital Signals in Chronic Pain (DiSCover Project)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03421223
Recruitment Status : Recruiting
First Posted : February 5, 2018
Last Update Posted : February 5, 2018
Sponsor:
Information provided by (Responsible Party):
Evidation Health

Brief Summary:
The DiSCover Project is a 1-year longitudinal case-control observational study. In this study, the investigators plan to collect different types of data including self-reported health outcomes and quality of life data, behavioral data from activity trackers and health and fitness apps, data from lab tests, genetic data, and environmental data. One of the goals of this study is to develop digital biomarkers for chronic pain severity, flare ups and quality of life.

Condition or disease Intervention/treatment
Chronic Pain Other: No intervention

Study Type : Observational
Estimated Enrollment : 10000 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Digital Signals in Chronic Pain (DiSCover Project)
Estimated Study Start Date : February 15, 2018
Estimated Primary Completion Date : March 8, 2019
Estimated Study Completion Date : March 8, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Chronic Pain

Group/Cohort Intervention/treatment
Case
Individuals diagnosed with chronic pain
Other: No intervention
No intervention

Control
Individuals without chronic pain
Other: No intervention
No intervention




Primary Outcome Measures :
  1. Self-reported chronic pain severity measured by BPI-SF [ Time Frame: 1 year ]
  2. Quality of Life Scale for Pain [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
This study will recruit virtually and individuals can participate remotely.
Criteria

Inclusion Criteria:

  • Age 18 years or older
  • Resides in the United States
  • Case Inclusion Criteria: Self-reported diagnosis of chronic pain and experiences moderate chronic pain as assessed by scoring at least 4 on the Numeric Pain Rating Scale
  • Control Inclusion Criteria: Self-reported not having chronic pain

Exclusion Criteria:

  • Less than 18 years old
  • Is not able to read or understand English

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03421223


Contacts
Contact: Jessie L Juusola, PhD 650-279-8855 jjuusola@evidation.com
Contact: Shefali Kumar, MPH skumar@evidation.com

Locations
United States, California
Evidation Health Recruiting
San Mateo, California, United States, 94401
Contact: Jessie L Juusola, PhD    650-279-8855    jjuusola@evidation.com   
Sponsors and Collaborators
Evidation Health
Investigators
Principal Investigator: Jessie L Juusola, PhD Evidation Health

Responsible Party: Evidation Health
ClinicalTrials.gov Identifier: NCT03421223     History of Changes
Other Study ID Numbers: EH-007
First Posted: February 5, 2018    Key Record Dates
Last Update Posted: February 5, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Chronic Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms